1Gillespie KM,Gah EA,Bingley PJ. High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes, 2002 51 :210-214.
2Mbanya JC,Sobngwi E, Mbanya DN. HLA-DRBI, -DQAI, DQBI and DPBI susceptibility alleles in Cameroonian type 1 diabetes patients and controls. Eur J Immunogenet, 2001,28:459-462.
3Toussirot E, Sauvageot C, Chabod J, et al. The association of HLA-DM genes with rueumatoid arthritis in Eastern France. Hum Immunol, 2000,61:303-308.
4Cucchi-MP,Carcassi C, Sorba Pet al. Implication of HLA-DMA alleles in Corsican IDDM. DisMarkrs , 1998,14 : 135-141.
5Siegmund T, Donner H, Braun .I, et al. HLA-DMA and HLA-DMB alleles in German patients with type 1 diabetes mellitus. Tissue Antigens, 1999,54:291-294.
6Singal DP, Ye M. HLA-DM polymorphisms in patients with Rheumatoid Arthritis. J Rheumat, 1998,25 : 1295-1298.
7Mosyak L, Zaller DM, Wiley DC. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class Ⅱ MHC molecules during antigen presentation. Immunity , 1998,9:377-383.
8Wubbolts R, Neefies J. Intracellular transport and peptide loading of MHC class II molecules: regulation by chaperones and motors.Immunol Rev, 1999,172 : 189-208.
9Sulabha S, Pathak JD. L, Janice S. B. Cutting Edge: Editing of Recycling Class Ⅱ: Peptide Complexes by HLA-DM. J Immunol,2001,167:632- 635.
10Bakke O, Nordeng TW. Intracellar traffic to compartments for MHC class Ⅱ peptide loading:signals for endosomal and polarized sorting.Immunol Rev , 1999,172 : 171-187.
